CA
ELAN icon

Claris Advisors’s Elanco Animal Health ELAN Stock Holding History

Claris Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33
Closed -$485 – 389
2024
Q3 		$485 Buy
+33
New +$460 ﹤0.01% 663

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Claris Advisors's ELAN Position: Q4 2024 in Review

Claris Advisors sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 33 shares — an estimated $485 sold.

Claris Advisors first reported a position in ELAN in Q3 2024 and held it in 1 quarter. The position peaked at $485 in Q3 2024. 394 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • Claris Advisors reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • Claris Advisors sold 33 Elanco Animal Health shares in Q4 2024, an estimated $485.
  • Claris Advisors first reported a position in Elanco Animal Health in Q3 2024 and held it in 1 quarter.
  • Claris Advisors's Elanco Animal Health position peaked at $485 in Q3 2024.
  • 394 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.